Industry
Featured experience
Novo Nordisk acquisition of certain Catalent sites from Novo Holdings
We are advising Novo Nordisk on the acquisition
AbbVie $15 billion senior notes offering
The investment-grade offering comprised seven tranches
Auna $360 million U.S. IPO
We advised Auna on its U.S. IPO and NYSE listing
Trial victory in patent infringement case for Magnolia Medical Technologies
We served as lead trial counsel for Magnolia Medical in an action against its sole competitor
Davis Polk Advises ViewRay, Inc. on Its $59 Million Direct-Registered Equity Offering
Davis Polk advised ViewRay, Inc. in a direct-registered offering of 7,090,581 shares of ViewRay’s common stock and 1,418,116…
Celgene $4.5 Billion Notes Offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters on an SEC-registered…
Avadel Pharmaceuticals $143.7 Million Exchangeable Senior Notes Offering
Davis Polk advised the initial purchasers on a Rule 144A offering by Avadel Finance Cayman Limited, a wholly owned…
Davis Polk Advises Affimed on Its $26.5 Million Offering of Shares
Davis Polk advised Affimed N.V. on its $26.5 million public offering of 13,225,000 of its common shares. Included in the…
Davis Polk Advises Roche on Its Acquisition of Flatiron Health
Davis Polk is advising Roche on its $1.9 billion acquisition of Flatiron Health, Inc. The transaction, which is expected to…
Davis Polk Advises Charles River on Its Acquisition of MPI Research
Davis Polk is advising Charles River Laboratories International, Inc. on its approximately $800 million acquisition of MPI…
Seattle Genetics, Inc. $600 Million Equity Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with an SEC…
Varian Medical Systems Acquires Sirtex Medical
Davis Polk is advising J.P. Morgan Securities LLC as financial adviser to Varian Medical Systems, Inc. in connection with…
Solid Biosciences Inc. Initial Public Offering
Davis Polk advised the joint book-running managers in connection with the $133.7 million initial public offering of common…
ConforMIS, Inc. Common Stock Offering
Davis Polk advised the joint book-running managers and representatives of the underwriters in connection with the SEC…